Operating Lease, Right-of-Use Asset of NKGen Biotech, Inc. from 31 Dec 2022 to 31 Mar 2025

Taxonomy & unit: us-gaap: USD
Description: Amount of lessee's right to use underlying asset under operating lease.
Summary: NKGen Biotech, Inc. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Dec 2022 to 31 Mar 2025.
NKGen Biotech, Inc. Operating Lease, Right-of-Use Asset for the quarter ending 31 Mar 2025 was $341,000, a 29% decline year-over-year.
Source SEC data: View on sec.gov

Operating Lease, Right-of-Use Asset, Quarterly (USD)

Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

NKGen Biotech, Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed	Fiscal Year	Fiscal Period
Q1 2025	$341,000	-$141,000	-29%	31 Mar 2025	10-Q	20 Jan 2026	2025	Q1
Q4 2024	$379,000	+$379,000		31 Dec 2024	10-Q	20 Jan 2026	2025	Q1
Q3 2024	$415,000	+$326,000	+366%	30 Sep 2024	10-Q	04 Mar 2025	2024	Q3
Q2 2024	$450,000			30 Jun 2024	10-Q	12 Sep 2024	2024	Q2
Q1 2024	$482,000			31 Mar 2024	10-Q	20 May 2024	2024	Q1
Q4 2023	$0	-$362,000	-100%	31 Dec 2023	10-K	08 Oct 2025	2024	FY
Q3 2023	$89,000			30 Sep 2023	10-Q	14 Nov 2023	2023	Q3
Q4 2022	$362,000			31 Dec 2022	10-K	16 Apr 2024	2023	FY

* An asterisk sign (*) next to the value indicates that the value is likely invalid.